- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 213/48 - Radicaux aldéhyde
Détention brevets de la classe C07D 213/48
Brevets de cette classe: 34
Historique des publications depuis 10 ans
|
2
|
5
|
2
|
2
|
0
|
0
|
0
|
3
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Gilead Sciences, Inc. | 2243 |
6 |
| HotSpot Therapeutics, Inc. | 41 |
3 |
| ExxonMobil Chemical Patents Inc. | 3760 |
2 |
| Arizona Board of Regents on behalf of Arizona State University | 2975 |
2 |
| BASF SE | 21328 |
1 |
| Evonik Degussa GmbH | 1346 |
1 |
| California Institute of Technology | 4038 |
1 |
| Daiichi Sankyo Company, Limited | 1889 |
1 |
| DSM Fine Chemicals Austria NFG GmbH & Co KG | 16 |
1 |
| EpiTherapeutics ApS | 5 |
1 |
| Fibrostatin, Sociedad Limitada | 10 |
1 |
| Fudan University | 769 |
1 |
| Global Blood Therapeutics, Inc. | 167 |
1 |
| M. Technique Co., Ltd. | 252 |
1 |
| Osaka University | 3258 |
1 |
| Piramal Enterprises Limited | 151 |
1 |
| Riken | 1722 |
1 |
| The United States of America, as represented by the Secretary, Department of Health & Human Services | 220 |
1 |
| University of Copenhagen | 441 |
1 |
| Neurosearch A/S | 142 |
1 |
| Autres propriétaires | 5 |